Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global oncology based in-vivo CRO market size was valued at USD 1.19 billion in 2023, driven by the development of non-viral delivery systems across the globe. The market is anticipated to grow at a CAGR of 7.9% during the forecast period of 2024-2032 to achieve a value of USD 2.35 billion by 2032.
Oncology based in-vivo CRO provides specialized services in the field of oncology research. A diverse range of services is provided by this organization in order to support the development of new oncology therapies and treatments. The main services provided by Oncology based In-Vivo CRO are study design, selection and validation of animal model, data collection and analysis, and regulatory compliance, along with dosing and drug administration, and tumor imaging and measurement.
The specialized CROs provide knowledge and experience in the conduct of investigations and tests employing in vivo models, such as animal models, to assess the efficacy and safety of new oncology treatments. Through the use of in vivo tumor models, xenograft and syngeneic models, pharmacokinetic investigations, toxicological analyses, and efficacy studies, in-vivo CROs offer thorough evaluation of potential oncology medications. They aid in finding indicators of therapy response or resistance, helping to test novel cancer therapies, and analyzing how treatments affect tumor growth and metastasis.
Expert services are provided by these organizations due to the access they have to advanced technologies and equipment that are required and necessary to conduct in-vivo studies. The expansion of personalized medicine owing to the market growth. By offering preclinical services that promote the development of targeted medicines and ease the discovery and validation of biomarkers, in-vivo CROs are significantly contributing to the advancement of personalized medicine. Additionally, the field of immuno-oncology harnesses the body's immune system to fight cancer has also been witnessing significant growth, leading to further oncology based in-vivo CRO market expansion.
In-Vivo CROs actively conducting preclinical studies to evaluate the efficacy and safety of immunotherapies and combination therapies to support the immuno-oncology research, propelling the oncology based in-vivo CRO market growth. The increased integration of artificial intelligence and machine learning technologies to improve the quality of data analysis, image processing, and predictive modeling are directly contributing to the market growth. In-Vivo CROs are the technologies that enables better interpretation of complex preclinical data and facilitate the identification of novel biomarkers, improving decision-making processes and accelerating drug discovery efforts.
Market Breakup by Indication
Market Breakup by Model
Market Breakup by Region
The market for oncology based in-vivo CRO has been witnessing evident growth in the past and is expected to see the growth in coming years as well owing to the increasing prevalence of cancer worldwide. The demand for newly developed therapies that are effective and innovative has increased and has created an emphasis on research and development for these therapies in the oncology filed. The demand for cost-effective and time-efficient drug development procedures has also been a driver for market growth.
In-vivo CROs provide specialised knowledge in creating and using animal models that closely resemble the characteristics of human cancers, enabling the assessment of targeted treatments and individualised treatment plans. This is further aiding the oncology based in-vivo CRO market development.
To ensure that only the highest-quality products are let onto the market, health authorities have established strict regulatory restrictions on pharmaceutical businesses. In-Vivo CROs help these companies adhere to these regulations. In-Vivo CROs assist in ensuring that potential oncology treatments meet the requisite safety and efficacy requirements for further development and clinical trials by conducting preclinical research in accordance with Good Laboratory Practise (GLP) standards which directly contributes to the market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Indication |
|
Breakup by Model |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
The market attained a value of about USD 1.19 billion in 2023, driven by the increasing demand for newly developed therapies.
The market is anticipated to grow at a CAGR of 7.9% during the forecast period of 2024-2032 to reach a market value of USD 2.35 million by 2032.
The increasing demand for cost-effective and time-efficient drug development procedures are among the key drivers aiding the market growth.
The technological advancement in the imaging process and demand for personalized medicine market are the key trends driving the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The models in the market include syngeneic xenograft and patient derived xenograft (PDX).
The different indications of oncology based In-Vivo CRO include blood cancer, solid tumors, other indications.
Key players involved in the market include Crown Bioscience Inc., Charles River Laboratories Inc., ICON PLC, Taconic Biosciences Inc., Covance Inc., Eurofins Scientific, EVOTEC, The Wuxi AppTec., MI Bioresearch Inc., and Jackson Laboratory.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124